Zai Lab Believes its Engagement of KPMG LLP is Consistent with PCAOB Requirements and Complies with the HFCAA
Sep 29, 2022
Read MoreSeagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK® (tisotumab vedotin-tftv)
Sep 27, 2022
Read MoreZai Lab to Present Analysis of the Impact of Timing for ZEJULA® (niraparib) Maintenance Treatment in Newly Diagnosed Advanced Ovarian Cancer at the 2022 International Gynecologic Cancer Society Meeting
Sep 20, 2022
Read MoreZai Lab’s Statement Regarding U.S./China Agreement Concerning PCAOB Inspection and Review of Auditors
Aug 26, 2022
Read MoreZai Lab Announces Second Quarter 2022 Financial Results and Corporate Updates
Aug 09, 2022
Read MoreZai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia
Aug 08, 2022
Read More